Ignite Creation Date:
2024-05-05 @ 9:28 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00890149
Status:
TERMINATED
Last Update Posted:
2023-05-26
First Post:
2009-04-27
Brief Title:
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
Status:
TERMINATED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Difficulty recruiting target sample
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy of ondansetron BASICS Plus in reducing severe or binge drinking among emerging adults BASIC Plus Brief Alcohol Screening and Intervention for College Students has been the most validated brief intervention among college students The BASICS program provides personal feedback motivation and strategies that enhance normative drinking patterns
Detailed Description:
We propose to conduct a 9 week study to test the efficacy of ondansetron in a heavy drinking non-dependent emerging adult population We will enroll individuals between the ages of 18 and 25 years as this period overlaps with the general population of those attending college and who can be defined as emerging adults We will conduct a double-blind control study in which 150 individuals will be randomized into 2 groups therefore the N will be 300
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2R01AA010522-13 | NIH | None | httpsreporternihgovquickSearch2R01AA010522-13 |